• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma.

作者信息

Colloby P S, West K P, Fletcher A

机构信息

Department of Pathology, Leicester Royal Infirmary, U.K.

出版信息

J Pathol. 1991 Mar;163(3):245-50. doi: 10.1002/path.1711630310.

DOI:10.1002/path.1711630310
PMID:2013827
Abstract

We have assessed the degree of observer variation of both Breslow depth and Clark's level in a series of 50 thin malignant melanomas. Our findings are similar to those of previous international studies in the Breslow depth is the more reproducible measure. Significant intra- and inter-observer variation exists and in some cases it was up to +/- 0.86 mm. Even small differences will potentially affect patient management at our centre and this was analysed using kappa statistics. Good agreement was found between observers and this could be improved by comparing the mean of two or more measurements. This removes larger errors, but smaller observer errors and differences in subjective interpretation of the deepest malignant cell mean that agreement will never be more than 90 per cent. This is high compared with studies of observer variation in other pathological conditions, e.g., dysplasia of the cervix, but where surgical management is potentially disfiguring it is not high enough. We conclude that Breslow depth and Clark's level should not be the sole basis of wide excision protocols.

摘要

相似文献

1
Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma.
J Pathol. 1991 Mar;163(3):245-50. doi: 10.1002/path.1711630310.
2
Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.关键预后参数(尤其是克拉克分级)的组织病理学报告中观察者间的差异,会影响原发性皮肤黑色素瘤的病理分期。
Ann Surg. 2009 Apr;249(4):641-7. doi: 10.1097/SLA.0b013e31819ed973.
3
Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.高危薄型黑色素瘤的识别应基于 Breslow 深度而非 Clark 四级。
Cancer. 2001 Mar 1;91(5):983-91.
4
Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.原发性皮肤恶性黑色素瘤的浸润深度和肿瘤厚度。一项对2012例病例的研究。
Acta Pathol Microbiol Immunol Scand A. 1985 Mar;93(2):49-55.
5
[Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].[皮肤恶性黑色素瘤的不寻常及未知方面:微小偏离恶性黑色素瘤。45例回顾性研究]
Ann Dermatol Venereol. 1985;112(4):325-36.
6
Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.皮肤原发性和转移性恶性黑色素瘤中MIB-1阳性和阴性肿瘤细胞的核形态测定
Pol J Pathol. 1999;50(4):235-41.
7
[Malignant melanoma (review of 68 cases)].[恶性黑色素瘤(68例病例回顾)]
Med Cutan Ibero Lat Am. 1986;14(6):391-6.
8
[Epidemiology and prognostic factors in cutaneous malignant melanoma].[皮肤恶性黑色素瘤的流行病学及预后因素]
Harefuah. 1995 Jun 15;128(12):745-51, 824.
9
Symptoms and signs of primary melanoma: important indicators of Breslow depth.原发性黑色素瘤的症状和体征:布雷斯洛厚度的重要指标。
Cancer. 2003 Jul 15;98(2):344-8. doi: 10.1002/cncr.11513.
10
[Prognostic factors in thin cutaneous malignant melanoma].[薄型皮肤恶性黑色素瘤的预后因素]
Pathologica. 2002 Dec;94(6):282-9. doi: 10.1007/s102420200051.

引用本文的文献

1
Histopathologic synoptic reporting of invasive melanoma: How reliable are the data?黑色素瘤侵袭性的组织病理综合报告:数据有多可靠?
Cancer. 2021 Sep 1;127(17):3125-3136. doi: 10.1002/cncr.33612. Epub 2021 May 4.
2
Pathologists' agreement on treatment suggestions for melanocytic skin lesions.病理学家对黑素细胞性皮肤病变治疗建议的一致性。
J Am Acad Dermatol. 2020 Jun;82(6):1435-1444. doi: 10.1016/j.jaad.2019.12.020. Epub 2019 Dec 17.
3
Current state of melanoma diagnosis and treatment.黑色素瘤的诊断与治疗现状。
Cancer Biol Ther. 2019;20(11):1366-1379. doi: 10.1080/15384047.2019.1640032. Epub 2019 Aug 1.
4
Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the .第 7 版与第 8 版 AJCC 黑色素瘤分期的一致性和可重复性。
JAMA Netw Open. 2018 May;1(1). doi: 10.1001/jamanetworkopen.2018.0083.
5
Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.病理学家对侵袭性黑色素瘤和黑素细胞增殖的诊断:观察者准确性和可重复性研究。
BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813.
6
The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.黑素细胞性增生及黑色素瘤的 MPATH-Dx 报告方案。
J Am Acad Dermatol. 2014 Jan;70(1):131-41. doi: 10.1016/j.jaad.2013.07.027. Epub 2013 Oct 28.
7
The velocity of ultrasound in human primary melanoma tissue - implications for the clinical use of high resolution sonography.超声在人类原发性黑色素瘤组织中的速度——对高分辨率超声临床应用的启示
BMC Dermatol. 2001;1:1. doi: 10.1186/1471-5945-1-1. Epub 2001 Jun 28.
8
A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.一项关于薄皮恶性黑色素瘤诊断中观察者变异的全国性调查,包括MIN术语。结直肠癌黑色素瘤病理小组。
J Clin Pathol. 1997 Mar;50(3):202-5. doi: 10.1136/jcp.50.3.202.
9
Problems with registration of cutaneous malignant melanoma in England.英国皮肤恶性黑色素瘤登记方面的问题。
Br J Cancer. 1995 Jul;72(1):224-8. doi: 10.1038/bjc.1995.307.